Sunday, October 26, 2008

FDA And Future Nanoscale Drug Regulation

The future is here. The FDA is starting to wrestle with how to regulate the burgeoning area of nanoscale drug development. This is pretty fascinating and interesting stuff as reported in this American Society of Health-System Pharmacists (ASHP) news article, "FDA Gathers Information For Plans To Regulate Nanoscale Drugs." Here are a couple of things I found interesting . . .

  1. Existing methods for examining traditional-sized products may fall short at the nanoscale level
  2. There's a need to understand the potential benefits and hazards of smaller drug particles
  3. At what size does a drug become a nanoscale product?
  4. Nanoscale drugs are manipulated in ways that may change the chemical and physical properties of a substance, which may alter how the drug functions inside the body

Return Home: http://drughealth.blogspot.com/
Return to Mobile Home: http://drughealth.mofuse.mobi/

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways